Found 10 matching trials
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A
PHASE1Sobi.BIVV001-003 is an open-label, 2-period, fixed sequence study for intra...
Location
Sobi Investigational Site
A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate
N/AThe main aims of the study are to assess the safety profile of Adynovate as...
Location
Hamilton-Niagara Regional Hemophilia Treatment Centre
Intensive Replacement Treatment in Haemophilia Patients With Synovitis
PHASE4Background: Joint haemorrhage represents the most common type of bleeding e...
Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia A
PHASE4Individualised pharmacokinetic (PK)-guided dosing of extended half-life (EH...
Location
Pediatric department, Faculty of medicine, Chulalongkorn University
Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A
PHASE1Primary objective
• To assess the half-life of BIVV001, Standard Half-Life...
Location
Investigational Site Number :1000001
Monitoring of Anti-TFPI in Hemophilia
N/ADuring the development of anti-TFPI antibodies, thrombin generation assay (...
Location
Groupement hospitalier Est Hôpital Cardilogique Service d'hémostase clinique
Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA Patients
PHASE4To compare clinical outcomes before and after using combination between mod...
Location
King Chulalongkorn Memorial Hospital
Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia
N/AIntroduction: Hemophilia is a congenital coagulopathy characterised by recu...
Location
Universidad de Oviedo
EVALUATION of the OVERALL HAEMOSTATIC CAPACITY of MIM8 with GLOBAL HAEMOSTASIS ASSAYS and FIBRIN CLOT ULTRASTRUCTURE
N/AHemophilia A is an X linked disorder characterized by a deficiency in Facto...
Location
Centre de Référence Hémophilie, Hôpital Louis Pradel- Hospices Civils de Lyon
Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia A
PHASE2Recent studies have shown that pharmacokinetic (PK)-guided extended half-li...
Status
Active Not Recruiting
Location
Chulalongkorn University